The Nerve Repair And Regeneration Market size was estimated USD 8.0 billion in 2022 and is expected to reach USD 20.04 billion By 2030 at a CAGR of 12.17% during the forecast period of 2023-2030.
The leading firms' strong product pipelines and the increasing prevalence of neurological illnesses are what are propelling the market. Multiple technical advances that have improved the effectiveness of treating neurological illnesses are also anticipated to fuel market expansion. The neurological operations of outpatient clinics were interfered with as a result of various government containment measures during the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) pandemic. Because of social restriction measures, vulnerable patients with conditions like Parkinson's disease (PD) or dystonia patients receiving deep brain stimulation (DBS) were more likely to experience chronic stress, and their motor and psychiatric symptoms reportedly got worse.Additionally, the availability of numerous medicines for managing different Central Nervous System (CNS) illnesses, including Parkinson's disease and Alzheimer's, as well as the expanding range of Surgery s, are projected to support market expansion over the coming years. The Alzheimer's Association estimates that 6.5 million Americans aged 65 or older will have Alzheimer's disease in 2022.
.png)
DRIVERS
Increasing elderly population, rising focus on neuromodulation and neurostimulation technology, high incidence of nerve injuries, and rising government funding for neurological illness research.
There is a considerable need for nerve repair and regeneration products due to the rising frequency of neurological illnesses and the large number of occurrences of nerve injury. Globally, the geriatric population is also growing. The market is expanding as a result of the sizable elderly population base and the enormous frequency and incidence of nerve-related diseases among them. The development of neurostimulation and neuromodulation technologies, such as next-generation neurostimulation devices, corporate partnerships to introduce cutting-edge products, and the arrival of cutting-edge technologies are driving the market's expansion. The government's funding for research on the market's growth pace is further accelerated by research on neurological disorders.
RESTRAIN
High prices, regulatory difficulties, and scant clinical evidence.
OPPORTUNITY
Emerging markets, improvements in stem cell therapy for nerve repair and regeneration, and expanding neurology research programs.
With their large populations, rising rates of neurological illnesses, improving healthcare infrastructure, and rising healthcare spending, emerging economies like India, China, and Brazil present lucrative market opportunities. With several stem cell therapies being tested for nerve repair and regeneration reasons, the new stem cell therapy technologies also present the market with enormous potential opportunities. The past few years have seen an upsurge in the amount of neurology research being done.
CHALLENGES
Lack of qualified doctors, morbidity at donor sites,big nerve gap treatment challenges, time-consuming approval procedures, and strict regulatory frameworks More people are choosing pharmacological therapies than nerve regeneration and repair products.
Access to Medical Facilities Patients' ability to obtain nerve repair and regeneration treatments may be impacted if access to medical facilities and healthcare services is impeded in areas that are directly affected by conflict. Economic Impact Economic downturns and currency fluctuations brought on by geopolitical instability can have an impact on government budgets and healthcare spending. This might have an effect on how much money is allocated to medical device research, healthcare programs, and research. Conflict-related resource reallocation and disruptions may have an influence on current research and development projects relating to medicines for nerve repair and regeneration. Access to the market and affordability Healthcare systems may find it difficult to provide access to specialist treatments and therapies in areas that are directly affected by violence. Economic challenges brought on by the conflict may make it more difficult for patients to pay for medical care.
IMPACT OF ONGOING RECESSION
Financial limitations Patients who are having trouble paying for care owing to the recession may put off getting procedures like nerve regeneration and repair if they believe they are not necessary. Patients' desire to undergo the operation and healthcare providers' capacity to invest in innovative technologies might both be impacted by lower disposable income. Reduced Healthcare Spending During a recession, healthcare systems may experience financial difficulties that result in a reduction in financing for some treatments and therapies, including technologies for nerve regeneration and repair. Research and Development Medical device businesses and academic institutions may have trouble acquiring funding for R&D initiatives, which could postpone the launch of cutting-edge solutions for nerve repair and regeneration.
By Product
Biomaterials
Neurostimulation and Neuromodulation Devices
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
By Surgery
Direct Nerve Repair/Neurorrhaphy
Nerve Grafting
Stem Cell Therapy
Neurostimulation and Neuromodulation Surgeries
.png)
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
REGIONAL ANALYSES
In 2022, North America dominated the market with over 30.8% of the market due to the region's favorable health insurance coverage environment and rising frequency of neurological illnesses. Due to the presence of significant market players, technologically improved equipment is readily available in this area, which is a primary driver of its development.
Due to its expanding target market, growing patient awareness, encouraging government initiatives, the existence of unmet medical requirements, and the introduction of cutting-edge technology, the Asia-Pacific region is anticipated to experience the fastest rate of growth in the area over the forecast period. China, India, Japan, Australia, and Singapore are the principal nations fostering regional development.
The major key players are AxoGen, Inc, Stryker Corporation, St. Jude Medical, Inc, Baxter International, Inc, Polyganics B.V, Boston Scientific, Inc, Integra Lifesciences Corporation, Cyberonics, Inc, Medtronic plc and others.
Medtronic: In 2022, The Vanta and Intellis neurostimulators made by Medtronic were given FDA approval to treat diabetic peripheral neuropathy (DPN)-related chronic pain.
Stimview XT: In 2022, Vercise Neural Navigator with Stimview XT, image-guided software from Boston Scientific, has been given FDA approval for deep brain stimulation therapy in Parkinson's disease patients.
| Report Attributes | Details |
| Market Size in 2022 | US$ 8.0 Bn |
| Market Size by 2030 | US$ 20.04 Bn |
| CAGR | CAGR of 12.17 % From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Biomaterials, Neurostimulation and Neuromodulation Devices, Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices) • By Surgery (Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation and Neuromodulation Surgeries) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | AxoGen, Inc, Stryker Corporation, St. Jude Medical, Inc, Baxter International, Inc, Polyganics B.V, Boston Scientific, Inc, Integra Lifesciences Corporation, Cyberonics, Inc, Medtronic plc |
| Key Drivers | • Increasing elderly population, rising focus on neuromodulation and neurostimulation technology, high incidence of nerve injuries, and rising government funding for neurological illness research. |
| Market Restraints | • High prices, regulatory difficulties, and scant clinical evidence. |
Ans: The Nerve Repair And Regeneration Market is expected to grow at 12.17% CAGR from 2023 to 2030.
Ans: According to our analysis, the Nerve Repair And Regeneration Market is anticipated to reach USD 20.04 billion By 2030.
Ans: The leading participants in the,AxoGen, Inc, Stryker Corporation, St. Jude Medical, Inc, Baxter International, Inc, Polyganics B.V, Boston Scientific, Inc.
Ans: Increased government funding and reimbursements, rising neurological disorder incidences, and expanding medical tourism are some of the main reasons propelling the market expansion for nerve repair and regeneration.
Ans: Yes, you may request customization based on your company's needs.
TABLE OF CONTENT
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8.Nerve Repair And Regeneration Market,By Product
8.1 Biomaterial
8.2 Neurostimulation and Neuromodulation Devices
8.3 Spinal Cord Stimulation Devices
8.4 Deep Brain Stimulation Devices
8.5 Sacral Nerve Stimulation Devices
8.6 Vagus Nerve Stimulation Devices
8.7 Gastric Electric Stimulation Devices
9. Nerve Repair And Regeneration Market, By Surgery
9.1 Direct Nerve Repair/Neurorrhaphy
9.2 Nerve Grafting
9.3 Stem Cell Therapy
9.4 Neurostimulation and Neuromodulation Surgeries
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Nerve Repair And Regeneration Market, by Country
10.2.2North America Nerve Repair And Regeneration Market, By Product
10.2.3 North America Nerve Repair And Regeneration Market, By Surgery
10.2.4 USA
10.2.4.1 USA Nerve Repair And Regeneration Market, By Product
10.2.4.2 USA Nerve Repair And Regeneration Market, By Surgery
10.2.5 Canada
10.2.5.1 Canada Nerve Repair And Regeneration Market, By Product
10.2.5.2 Canada Nerve Repair And Regeneration Market, By Surgery
10.2.6 Mexico
10.2.6.1 Mexico Nerve Repair And Regeneration Market By Product
10.2.6.2 Mexico Nerve Repair And Regeneration Market By Surgery
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Eastern Europe Nerve Repair And Regeneration Market by Country
10.3.1.2 Eastern Europe Nerve Repair And Regeneration Market By Product
10.3.1.3 Eastern Europe Nerve Repair And Regeneration Market By Surgery
10.3.1.4 Poland
10.3.1.4.1 Poland Nerve Repair And Regeneration Market By Product
10.3.1.4.2 Poland Nerve Repair And Regeneration Market By Surgery
10.3.1.5 Romania
10.3.1.5.1 Romania Nerve Repair And Regeneration Market By Product
10.3.1.5.2 Romania Nerve Repair And Regeneration Market By Surgery
10.3.1.6 Hungary
10.3.1.6.1 Hungary Nerve Repair And Regeneration Market By Product
10.3.1.6.2 Hungary Nerve Repair And Regeneration Market By Surgery
10.3.1.7 Turkey
10.3.1.7.1 Turkey Nerve Repair And Regeneration Market By Product
10.3.1.7.2 Turkey Nerve Repair And Regeneration Market By Surgery
10.3.1.8 Rest of Eastern Europe
10.3.1.8.1 Rest of Eastern Europe Nerve Repair And Regeneration Market By Product
10.3.1.8.2 Rest of Eastern Europe Nerve Repair And Regeneration Market By Surgery
10.3.2 Western Europe
10.3.2.1 Western Europe Nerve Repair And Regeneration Market by Country
10.3.2.2 Western Europe Nerve Repair And Regeneration Market By Product
10.3.2.3 Western Europe Nerve Repair And Regeneration Market By Surgery
10.3.2.4 Germany
10.3.2.4.1 Germany Nerve Repair And Regeneration Market By Product
10.3.2.4.2 Germany Nerve Repair And Regeneration Market By Surgery
10.3.2.5 France
10.3.2.5.1 France Nerve Repair And Regeneration Market By Product
10.3.2.5.2 France Nerve Repair And Regeneration Market By Surgery
10.3.2.6 UK
10.3.2.6.1 UK Nerve Repair And Regeneration Market By Product
10.3.2.6.2 UK Nerve Repair And Regeneration Market By Surgery
10.3.2.7 Italy
10.3.2.7.1 Italy Nerve Repair And Regeneration Market By Product
10.3.2.7.2 Italy Nerve Repair And Regeneration Market By Surgery
10.3.2.8 Spain
10.3.2.8.1 Spain Nerve Repair And Regeneration Market By Product
10.3.2.8.2 Spain Nerve Repair And Regeneration Market By Surgery
10.3.2.9 Netherlands
10.3.2.9.1 Netherlands Nerve Repair And Regeneration Market By Product
10.3.2.9.2 Netherlands Nerve Repair And Regeneration Market By Surgery
10.3.2.10 Switzerland
10.3.2.10.1 Switzerland Nerve Repair And Regeneration Market By Product
10.3.2.10.2 Switzerland Nerve Repair And Regeneration Market By Surgery
10.3.2.11 Austria
10.3.2.11.1 Austria Nerve Repair And Regeneration Market By Product
10.3.2.11.2 Austria Nerve Repair And Regeneration Market By Surgery
10.3.2.12 Rest of Western Europe
10.3.2.12.1 Rest of Western Europe Nerve Repair And Regeneration Market By Product
10.3.2.12.2 Rest of Western Europe Nerve Repair And Regeneration Market By Surgery
10.4 Asia-Pacific
10.4.1 Asia Pacific Nerve Repair And Regeneration Market by Country
10.4.2 Asia Pacific Nerve Repair And Regeneration Market By Product
10.4.3 Asia Pacific Nerve Repair And Regeneration Market By Surgery
10.4.4 China
10.4.4.1 China Nerve Repair And Regeneration Market By Product
10.4.4.2 China Nerve Repair And Regeneration Market By Surgery
10.4.5 India
10.4.5.1 India Nerve Repair And Regeneration Market By Product
10.4.5.2 India Nerve Repair And Regeneration Market By Surgery
10.4.6 Japan
10.4.6.1 Japan Nerve Repair And Regeneration Market By Product
10.4.6.2 Japan Nerve Repair And Regeneration Market By Surgery
10.4.7 South Korea
10.4.7.1 South Korea Nerve Repair And Regeneration Market By Product
10.4.7.2 South Korea Nerve Repair And Regeneration Market By Surgery
10.4.8 Vietnam
10.4.8.1 Vietnam Nerve Repair And Regeneration Market By Product
10.4.8.2 Vietnam Nerve Repair And Regeneration Market By Surgery
10.4.9 Singapore
10.4.9.1 Singapore Nerve Repair And Regeneration Market By Product
10.4.9.2 Singapore Nerve Repair And Regeneration Market By Surgery
10.4.10 Australia
10.4.10.1 Australia Nerve Repair And Regeneration Market By Product
10.4.10.2 Australia Nerve Repair And Regeneration Market By Surgery
10.4.11 Rest of Asia-Pacific
10.4.11.1 Rest of Asia-Pacific Nerve Repair And Regeneration Market By Product
10.4.11.2 Rest of Asia-Pacific Nerve Repair And Regeneration Market By Surgery
10.5 Middle East & Africa
10.5.1 Middle East
10.5.1.1 Middle East Nerve Repair And Regeneration Market by Country
10.5.1.2 Middle East Nerve Repair And Regeneration Market By Product
10.5.1.3 Middle East Nerve Repair And Regeneration Market By Surgery
10.5.1.4 UAE
10.5.1.4.1 UAE Nerve Repair And Regeneration Market By Product
10.5.1.4.2 UAE Nerve Repair And Regeneration Market By Surgery
10.5.1.5 Egypt
10.5.1.5.1 Egypt Nerve Repair And Regeneration Market By Product
10.5.1.5.2 Egypt Nerve Repair And Regeneration Market By Surgery
10.5.1.6 Saudi Arabia
10.5.1.6.1 Saudi Arabia Nerve Repair And Regeneration Market By Product
10.5.1.6.2 Saudi Arabia Nerve Repair And Regeneration Market By Surgery
10.5.1.7 Qatar
10.5.1.7.1 Qatar Nerve Repair And Regeneration Market By Product
10.5.1.7.2 Qatar Nerve Repair And Regeneration Market By Surgery
10.5.1.8 Rest of Middle East
10.5.1.8.1 Rest of Middle East Nerve Repair And Regeneration Market By Product
10.5.1.8.2 Rest of Middle East Nerve Repair And Regeneration Market By Surgery
10.5.2 Africa
10.5.2.1 Africa Nerve Repair And Regeneration Market by Country
10.5.2.2 Africa Nerve Repair And Regeneration Market By Product
10.5.2.3 Africa Nerve Repair And Regeneration Market By Surgery
10.5.2.4 Nigeria
10.5.2.4.1 Nigeria Nerve Repair And Regeneration Market By Product
10.5.2.4.2 Nigeria Nerve Repair And Regeneration Market By Surgery
10.5.2.5 South Africa
10.5.2.5.1 South Africa Nerve Repair And Regeneration Market By Product
10.5.2.5.2 South Africa Nerve Repair And Regeneration Market By Surgery
10.5.2.6 Rest of Africa
10.5.2.6.1 Rest of Africa Nerve Repair And Regeneration Market By Product
10.5.2.6.2 Rest of Africa Nerve Repair And Regeneration Market By Surgery
10.6 Latin America
10.6.1 Latin America Nerve Repair And Regeneration Market by Country
10.6.2 Latin America Nerve Repair And Regeneration Market By Product
10.6.3 Latin America Nerve Repair And Regeneration Market By Surgery
10.6.4 Brazil
10.6.4.1 Brazil Nerve Repair And Regeneration Market By Product
10.6.4.2 Brazil Nerve Repair And Regeneration Market By Surgery
10.6.5 Argentina
10.6.5.1 Argentina Nerve Repair And Regeneration Market By Product
10.6.5.2 Argentina Nerve Repair And Regeneration Market By Surgery
10.6.6 Colombia
10.6.6.1 Colombia Nerve Repair And Regeneration Market By Product
10.6.6.2 Colombia Nerve Repair And Regeneration Market By Surgery
10.6.7 Rest of Latin America
10.6.7.1 Rest of Latin America Nerve Repair And Regeneration Market By Product
10.6.7.2 Rest of Latin America Nerve Repair And Regeneration Market By Surgery
11 Company Profile
11.1 AxoGen, Inc.
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Type/Services Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Stryker Corporation.
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Type/Services Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 St. Jude Medical, Inc.
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Type/Services Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11. 3M Company.
11.4 Company Overview
11.4.2 Financials
11.4.3 Type/Services Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 Baxter International, Inc.
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Type/Services Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Polyganics B.V.
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Type/Services Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 Boston Scientific, Inc.
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Type/Services Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 Integra Lifesciences Corporation.
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Type/Services Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 Cyberonics, Inc.
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Type/ Services Offered
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 Medtronic plc.
11.10.1 Company Overview
11.10.2 Financials
11.10.3 Type/Services Offered
11.10.4 SWOT Analysis
11.10.5 The SNS View
12. Competitive Landscape
12.1 Competitive Bench marking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions
13. USE Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Long-term Care Software Market Size was valued at USD 2.77 billion in 2022, and expected to reach USD 7.33 billion by 2030, and grow at a CAGR of 12.9% over the forecast period 2023-2030.
The Wireless Brain Sensors Market Size was valued at USD 476.84 million in 2022, and is expected to reach USD 992.80 million by 2030, and grow at a CAGR of 9.6% over the forecast period 2023-2030.
The IoT Medical Devices Market Size was valued at USD 46.34 billion in 2023, and expected to reach USD 309.71 billion by 2031, and grow at a CAGR of 26.81 % over the forecast period 2024-2031.
The Virtual Fitness Market size was valued at USD 20.54 billion in 2023 and is expected to reach approx. USD 137.25 billion by 2031, and grow at a CAGR of 26.81% over the forecast period of 2024-2031.
The Over-The-Counter Drugs Market size was valued at USD 175.6 billion in 2023 and is expected to reach at USD 275.7 billion by 2031, and grow at a CAGR of 5.80% over the forecast period of 2024-2031.
The Neurorehabilitation Market Size was assessed at USD 1.29 billion in 2022, and is predicted to increase at a CAGR of 9% from 2023 to 2030, to reach USD 2.58 billion.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
